141 related articles for article (PubMed ID: 30016012)
21. Schedules of controlled substances: placement of suvorexant into Schedule IV. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2014 Aug; 79(167):51243-7. PubMed ID: 25167596
[TBL] [Abstract][Full Text] [Related]
22. Schedules of Controlled Substances: Placement of Eluxadoline Into Schedule IV. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2015 Nov; 80(218):69861-4. PubMed ID: 26567437
[TBL] [Abstract][Full Text] [Related]
23. Schedules of Controlled Substances: Placement of AB-CHMINACA, ABPINACA and THJ-2201 Into Schedule I. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2017 Oct; 82(198):47971-4. PubMed ID: 29035496
[TBL] [Abstract][Full Text] [Related]
24. Schedules of controlled substances: temporary placement of four synthetic cannabinoids into Schedule I. Final order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2014 Feb; 79(27):7577-82. PubMed ID: 24605391
[TBL] [Abstract][Full Text] [Related]
25. Schedules of Controlled Substances: Placement of PB-22, 5F-PB-22, AB-FUBINACA and ADB-PINACA into Schedule I. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2016 Sep; 81(172):61130-3. PubMed ID: 27632803
[TBL] [Abstract][Full Text] [Related]
26. Schedules of Controlled Substances: Temporary Placement of FUB–AMB Into Schedule I. Temporary amendment; temporary scheduling order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2017 Nov; 82(212):51154-8. PubMed ID: 29098846
[TBL] [Abstract][Full Text] [Related]
27. Schedules of Controlled Substances: Placement of UR-144, XLR11, and AKB48 into Schedule I. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2016 May; 81(91):29142-5. PubMed ID: 27192731
[TBL] [Abstract][Full Text] [Related]
28. Schedules of Controlled Substances: Placement of Thiafentanil Into Schedule II. Interim final rule with request for comments.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2016 Aug; 81(166):58834-40. PubMed ID: 27568479
[TBL] [Abstract][Full Text] [Related]
29. Schedules of Controlled Substances: Placement of 10 Synthetic Cathinones Into Schedule I. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2017 Mar; 82(39):12171-7. PubMed ID: 28355044
[TBL] [Abstract][Full Text] [Related]
30. Schedules of controlled substances: rescheduling of hydrocodone combination products from schedule III to schedule II. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2014 Aug; 79(163):49661-82. PubMed ID: 25167591
[TBL] [Abstract][Full Text] [Related]
31. Schedules of controlled substances: temporary placement of three synthetic cannabinoids into schedule I. Final order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2015 Jan; 80(20):5042-7. PubMed ID: 25730924
[TBL] [Abstract][Full Text] [Related]
32. Schedules of controlled substances: temporary placement of 10 synthetic cathinones into Schedule I. Final order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2014 Mar; 79(45):12938-43. PubMed ID: 24611212
[TBL] [Abstract][Full Text] [Related]
33. Schedules of controlled substances: temporary placement of three synthetic phenethylamines into Schedule I. Final order.
Drug Enforcement Administration. Department of Justice
Fed Regist; 2013 Nov; 78(221):68716-9. PubMed ID: 24236337
[TBL] [Abstract][Full Text] [Related]
34. Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) into Schedule I. Temporary Scheduling Order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2017 Apr; 82(67):17119-24. PubMed ID: 28425681
[TBL] [Abstract][Full Text] [Related]
35. Schedules of Controlled Substances: Removal of Naldemedine From Control. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2017 Sep; 82(188):45436-8. PubMed ID: 28990740
[TBL] [Abstract][Full Text] [Related]
36. Schedules of controlled substances: removal of naloxegol from control. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2015 Jan; 80(15):3468-70. PubMed ID: 25730920
[TBL] [Abstract][Full Text] [Related]
37. Schedules of Controlled Substances: Removal of [123I]Ioflupane From Schedule II of the Controlled Substances Act. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2015 Sep; 80(176):54715-8. PubMed ID: 26364325
[TBL] [Abstract][Full Text] [Related]
38. Schedules of controlled substances: placement of tapentadol into schedule II. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2009 May; 74(97):23790-3. PubMed ID: 19507329
[TBL] [Abstract][Full Text] [Related]
39. Schedules of controlled substances: temporary placement of three synthetic cannabinoids into Schedule I. Final order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2013 May; 78(95):28735-9. PubMed ID: 23678676
[TBL] [Abstract][Full Text] [Related]
40. Schedules of controlled substances: placement of 5-methoxy-N,N-dimethyltryptamine into Schedule I of the Controlled Substances Act. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2010 Dec; 75(243):79296-300. PubMed ID: 21171485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
